ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM
ZHAOKE OPHTH-B: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM
ZHAOKE OPHTH-B: FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 17, 2024
ZHAOKE OPHTH-B: NOTICE OF ANNUAL GENERAL MEETING
ZHAOKE OPHTH-B: (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND (4) NOTICE OF ANNUAL GENERAL MEETING
ZHAOKE OPHTH-B: Environmental, Social and Governance Report 2023
ZHAOKE OPHTH-B: 2023 Annual Report
ZHAOKE OPHTH-B: CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD
ZHAOKE OPHTH-B: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
ZHAOKE OPHTH-B: RESIGNATION OF NON-EXECUTIVE DIRECTOR
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
ZHAOKE OPHTH-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
ZHAOKE OPHTH-B: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form
ZHAOKE OPHTH-B: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form
ZHAOKE OPHTH-B: NOTICE OF BOARD MEETING
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AGREEMENT WITH KWANGDONG PHARMACEUTICAL TO COMMERCIALIZE BRIMOCHOL PF IN THE REPUBLIC OF KOREA
ZHAOKE OPHTH-B: Voluntary Announcement - INVESTIGATIONAL NEW DRUG APPLICATIONS FOR CLINICAL TRIAL OF BRIMOCHOL PF AND CARBACHOL PF FOR THE TREATMENT OF PRESBYOPIA APPROVED BY NMPA
No Data